Parkinson's drug tested to stop diabetes from stealing sight
NCT ID NCT07444892
Summary
This study tested whether levodopa, a medication used for Parkinson's disease, could help protect the eyes of people with diabetes before visible damage occurs. 230 participants, including veterans, took either a placebo or different doses of levodopa for six months. Researchers used specialized eye tests to see if the drug could restore normal electrical activity in the retina and slow early diabetic eye disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Atlanta VA Medical Center
Decatur, Georgia, 30033, United States
Conditions
Explore the condition pages connected to this study.